European Cytokine Network

, Volume 29, Issue 1, pp 16–26 | Cite as

Associations between interleukin-10 polymorphisms and susceptibility to juvenile idiopathic arthritis: a systematic review and meta-analysis

  • Sara Harsini
  • Amene Saghazadeh
  • Saharnaz Nedjat
  • Nima Rezaei
Review
  • 1 Downloads

Abstract

Background

Cytokine genes, including interleukin-10 (IL-10), are known to play important roles in the pathogenesis of juvenile idiopathic arthritis (JIA). This study aims to determine whether the IL-10 polymorphisms confer susceptibility to JIA.

Methods

A meta-analysis was performed on the associations between the IL-10-1082 G/A, -592 C/A, and -819 C/T polymorphisms and JIA. A total number of 7 studies involving 1,785 patients and 6,142 controls were considered in the meta-analysis.

Results

Meta-analysis of the IL-10-592 C/A and -819 C/T polymorphisms showed no association with JIA in the study participants, or in Caucasian or Middle Eastern participants. Meta-analysis of the IL-10-1082 A allele in all study participants, Caucasian and Middle Eastern, showed significant associations with RA (overall ORs were 1.17, 1.15, and 1.41, respectively). Meta-analysis of the AA versus GG genotype of the IL-10-1082 G/A polymorphism revealed significant associations with JIA (OR = 3.66, 95% CI = 1.44-9.29, P = 0.006) in participants from Middle Eastern countries. Additionally, meta-analysis of the GG versus AA+GA genotypes of the IL-10 -1082 G/A polymorphism revealed the GG genotype as the protective factor against JIA in the Middle Eastern subgroup (OR = 0.44, 95% CI = 0.20-0.94, P = 0,04). Moreover, meta-analysis of the IL-10 -1082 A allele in 4 studies on Hardy-Weinberg equilibrium showed a significant association with JIA (OR = 1.17, 95% CI = 1.07-1.28, P = 0.0009). No association was found between the IL-10 (-1082, -819, -592) ACC, ATA, and GCC haplotypes and JIA.

Conclusions

These results suggest that the IL-10-1082 G/A polymorphism confers susceptibility to JIA.

Key words

juvenile idiopathic arthritis interleukin-10 polymorphism meta-analysis 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Symmons D, Jones M, Osborne J, Sills J, Southwood T, Woo P. Pediatric rheumatology in the United Kingdom: data from the British Pediatric Rheumatology Group National Diagnostic Register. J Rheumatol 1996; 23: 1975.PubMedGoogle Scholar
  2. 2.
    Petty RE, Southwood TR, Baum J, et al. Revision of the proposed classification criteria for juvenile idiopathic arthritis: Durban, 1997. J Rheumatol 1998; 25: 1991.PubMedGoogle Scholar
  3. 3.
    Donn R, Barrett J, Farhan A, et al. Cytokine gene polymorphisms and susceptibility to juvenile idiopathic arthritis. Arthritis Rheumatol 2001; 44: 802.CrossRefGoogle Scholar
  4. 4.
    Harsini S, Ziaee V, Maddah M, et al. Interleukin 10 and transforming growth factor beta 1 gene polymorphisms in juvenile idiopathic arthritis. Bratisl Lek Listy 2016; 117: 258.PubMedGoogle Scholar
  5. 5.
    Maddah M, Harsini S, Rezaei A, et al. Association of interleukin-2, but not interferon-gamma, single nucleotide polymorphisms with juvenile idiopathic arthritis. Allergol Immunopathol (Madr) 2016; 44: 303.CrossRefGoogle Scholar
  6. 6.
    Maddah M, Harsini S, Ziaee V, et al. Association of tumour necrosis factor-alpha G/A-238 and G/A-308 single nucleotide polymorphisms with juvenile idiopathic arthritis. Int J Immunogenet 2016; 43: 391.CrossRefPubMedGoogle Scholar
  7. 7.
    Ziaee V, Maddah M, Harsini S, et al. Association of interleukin-1 family gene polymorphisms with juvenile idiopathic arthritis in Iranian population. Allergol Immunopathol (Madr) 2016; 44: 542.CrossRefGoogle Scholar
  8. 8.
    Ziaee V, Maddah M, Moradinejad MH, et al. Association of interleukin-6 single nucleotide polymorphisms with juvenile idiopathic arthritis. Clin Rheumatol 2017; 36: 77.CrossRefPubMedGoogle Scholar
  9. 9.
    Ziaee V, Rezaei A, Harsini S, et al. Polymorphisms of genes encoding interleukin-4 and its receptor in Iranian patients with juvenile idiopathic arthritis. Clin Rheumatol 2016; 35: 1943.CrossRefPubMedGoogle Scholar
  10. 10.
    Cassatella MA, Meda L, Bonora S, Ceska M, Constantin G. Interleukin 10 (IL-10) inhibits the release of proinflammatory cytokines from human polymorphonuclear leukocytes. Evidence for an autocrine role of tumor necrosis factor and IL-1 beta in mediating the production of IL-8 triggered by lipopolysaccharide. J Exp Med 1993; 178: 2207.PubMedGoogle Scholar
  11. 11.
    Joosten LA, Lubberts E, Durez P, et al. Role of interleukin-4 and interleukin-10 in murine collagen-induced arthritis. Protective effect of interleukin-4 and interleukin-10 treatment on cartilage destruction. Arthritis Rheum 1997; 40: 249.PubMedGoogle Scholar
  12. 12.
    van Roon JA, van Roy JL, Gmelig-Meyling FH, Lafeber FP, Bijlsma JW. Prevention and reversal of cartilage degradation in rheumatoid arthritis by interleukin-10 and interleukin-4. Arthritis Rheum 1996; 39: 829.CrossRefPubMedGoogle Scholar
  13. 13.
    Jorgensen C, Apparailly F, Couret I, Canovas F, Jacquet C, Sany J. Interleukin-4 and interleukin-10 are chondroprotective and decrease mononuclear cell recruitment in human rheumatoid synovium in vivo. Immunology 1998; 93: 518.CrossRefPubMedPubMedCentralGoogle Scholar
  14. 14.
    Kawakami A, Eguchi K, Matsuoka N, et al. Inhibitory effects of interleukin-10 on synovial cells of rheumatoid arthritis. Immunology 1997; 91: 252.CrossRefPubMedPubMedCentralGoogle Scholar
  15. 15.
    Omoyinmi E, Forabosco P, Hamaoui R, et al. Association of the IL-10 gene family locus on chromosome 1 with juvenile idiopathic arthritis (JIA). PLoS One 2012; 7: e47673.CrossRefGoogle Scholar
  16. 16.
    Eskdale J, Wordsworth P, Bowman S, Field M, Gallagher G. Association between polymorphisms at the human IL-10 locus and systemic lupus erythematosus. Tissue Antigens 1997; 49: 635.CrossRefPubMedGoogle Scholar
  17. 17.
    Cinek O, Vavrincová P, Striz I, et al. Association of single nucleotide polymorphisms within cytokine genes with juvenile idiopathic arthritis in the Czech population. J Rheumatol 2004; 31: 1206.PubMedGoogle Scholar
  18. 18.
    Crawley E, Kay R, Sillibourne J, Patel P, Hutchinson I, Woo P. Polymorphic haplotypes of the interleukin-10 5’ flanking region determine variable interleukin-10 transcription and are associated with particular phenotypes of juvenile rheumatoid arthritis. Arthritis Rheum 1999; 42: 1101.CrossRefPubMedGoogle Scholar
  19. 19.
    Donn RP, Barrett JH, Farhan A, et al. Cytokine gene polymorphisms and susceptibility to juvenile idiopathic arthritis. Arthritis Rheum 2001; 44: 802.CrossRefPubMedGoogle Scholar
  20. 20.
    Fathy MM, Elsaadany HF, Ali YF, et al. Association of IL-10 gene polymorphisms and susceptibility to juvenile idiopathic arthritis in Egyptian children and adolescents: a case-control study. Ital JPediatr 2017; 43: 9.CrossRefGoogle Scholar
  21. 21.
    Fife MS, Gutierrez A, Ogilvie EM, et al. Novel IL10 gene family associations with systemic juvenile idiopathic arthritis. Arthritis Res Ther 2006; 8: R148.CrossRefPubMedPubMedCentralGoogle Scholar
  22. 22.
    Harsini S, Ziaee V, Maddah M, et al. Interleukin 10 and transforming growth factor beta 1 gene polymorphisms in juvenile idiopathic arthritis. Bratisl Lek Listy 2016; 117: 258.PubMedGoogle Scholar
  23. 23.
    Wells G, Shea B, O’connell D, et al. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. Oxford: Ottawa Hospital Research Institute, 2014, 2015.Google Scholar
  24. 24.
    Higgins J, Thompson SG. Quantifying heterogeneity in a metaanalysis. Stat Med 2002; 21: 1539.CrossRefPubMedGoogle Scholar
  25. 25.
    Minelli C, Thompson JR, Abrams KR, Thakkinstian A, Attia J. How should we use information about HWE in the metaanalyses of genetic association studies? Int J Epidemiol 2007; 37: 136.CrossRefPubMedGoogle Scholar
  26. 26.
    Rodriguez S, Gaunt TR, Day IN. Hardy-Weinberg equilibrium testing of biological ascertainment for Mendelian randomization studies. Am J Epidemiol 2009; 169: 505.CrossRefPubMedPubMedCentralGoogle Scholar
  27. 27.
    Thakkinstian A, McElduff P, D’Este C, Duffy D, Attia J. A method for meta-analysis of molecular association studies. Stat Med 2005; 24: 1291.CrossRefPubMedGoogle Scholar
  28. 28.
    Taga K, Tosato G. IL-10 inhibits human T cell proliferation and IL-2 production. J Immunol 1992; 148: 1143.PubMedGoogle Scholar
  29. 29.
    Tarzi M, Klunker S, Texier C, et al. Induction of interleukin-10 and suppressor of cytokine signalling-3 gene expression following peptide immunotherapy. Clin Exp Allergy 2006; 36: 465.CrossRefPubMedGoogle Scholar
  30. 30.
    Hee CS, Gun SC, Naidu R, Gupta E, Somnath SD, Radhakrishnan AK. Comparison of single nucleotide polymorphisms in the human interleukin-10 gene promoter between rheumatoid arthritis patients and normal subjects in Malaysia. Mod Rheumatol 2007; 17: 429.CrossRefPubMedGoogle Scholar
  31. 31.
    Martinez A, Pascual M, Pascual-Salcedo D, Balsa A, Martin J, De la Concha E. Genetic polymorphisms in Spanish rheumatoid arthritis patients: an association and linkage study. Genes Immun 2003; 4: 117.CrossRefPubMedGoogle Scholar
  32. 32.
    Müller K, Herner E, Stagg A, Bendtzen K, Woo P. Inflammatory cytokines and cytokine antagonists in whole blood cultures of patients with systemic juvenile chronic arthritis. Br J Rheumatol 1998; 37: 562.CrossRefPubMedGoogle Scholar

Copyright information

© John Libbey Eurotext 2018

Authors and Affiliations

  • Sara Harsini
    • 1
    • 2
  • Amene Saghazadeh
    • 1
    • 2
  • Saharnaz Nedjat
    • 3
  • Nima Rezaei
    • 1
    • 2
    • 4
    • 5
  1. 1.Research Center for Immunodeficiencies, Children’s Medical CenterTehran University of Medical SciencesTehranIran
  2. 2.Network of Immunity in Infection, Malignancy and Autoimmunity (NIIMA)Universal Scientific Education and Research Network (USERN)TehranIran
  3. 3.Epidemology and Biostatistics Department, School of Public Health, Knowledge Utilization Research CenterTehran University of medical SciencesTehranIran
  4. 4.Department of Immunology, School of MedicineTehran University of Medical SciencesTehranIran
  5. 5.Systematic Review and Meta-analysis Expert Group (SRMEG)Universal Scientific Education and Research Network (USERN)BostonUSA

Personalised recommendations